Impact of Impella Support on Clinical Outcomes in Patients with Postcardiotomy Cardiogenic Shock
Annals of Thoracic and Cardiovascular Surgery · 2024
DOI: 10.5761/atcs.oa.23-00076 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of Thoracic and Cardiovascular Surgery, 2024. Verfasst von Yukiharu Sugimura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery and Research Group for Experimental Surgery, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine Univers…. Hauptthemen laut MEDLINE: Heart-Assist Devices, Cardiac Surgical Procedures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE: This study aimed to elucidate the strategy of an effective Impella support for better clinical outcomes in patients with a postcardiotomy cardiogenic shock (PCCS). METHODS: This single-center retrospective observational study enrolled 31 patients with PCCS undergoing an elective open-heart surgery followed by Impella support between November 2018 and February 2022 for further analysis. RESULTS: The preoperative Euroscore II and left ventricular (LV) ejection fraction were 9.1 ± 10.4 and 35.7% ± 12.6%, respectively. The in-hospital mortality rate was 51.6% (n = 16). In survivors (n = 15), the mean Impella support time was 6.9 ± 3.5 days. Patients were discharged on the postoperative day 24.9 ± 16.4. Regarding LV remodeling, LV end-diastolic diameter was significantly decreased after Impella support (59.2 ± 6.0 mm vs. 54.4 ± 4.7 mm, p = 0.01, preoperative vs. postoperative). In-hospital mortality rates were comparable with small (CP, n = 6) or large (5.0, n = 25) Impella systems (33.3% [n = 2] vs. 56.0% [n = 14], p = 0.39). However, a lower in-hospital mortality rate was observed in the group with early initiation (i.e., intraoperative) of Impella support (n = 14) than that with delayed Impella initiation (i.e., in the postoperative course) (n = 11) (28.6% [n = 4] vs. 90.9% [n = 10], p = 0.004). CONCLUSIONS: Impella support contributes to LV remodeling in PCCS patients. In-hospital mortality was comparable in different Impella sizes and lower in early Impella initiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery and Research Group for Experimental Surgery, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Hospital, Düsseldorf, Germany.
- Department of Cardiac Surgery, Medical Faculty and RWTH University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
Zitieren
APA
Sugimura, Y., Immohr, M. B., Mehdiani, A., Boeken, U., Aubin, H., Lichtenberg, A., & Akhyari, P. (2024). Impact of Impella Support on Clinical Outcomes in Patients with Postcardiotomy Cardiogenic Shock. Annals of Thoracic and Cardiovascular Surgery. https://doi.org/10.5761/atcs.oa.23-00076
Vancouver
Sugimura Y, Immohr MB, Mehdiani A, Boeken U, Aubin H, Lichtenberg A, et al. Impact of Impella Support on Clinical Outcomes in Patients with Postcardiotomy Cardiogenic Shock. Annals of Thoracic and Cardiovascular Surgery. 2024. doi:10.5761/atcs.oa.23-00076
BibTeX
@article{Sugimura2024,
author = {Sugimura, Yukiharu and Immohr, Moritz Benjamin and Mehdiani, Arash and Boeken, Udo and Aubin, Hug and Lichtenberg, Artur and Akhyari, Payam},
title = {Impact of Impella Support on Clinical Outcomes in Patients with Postcardiotomy Cardiogenic Shock},
journal = {Annals of Thoracic and Cardiovascular Surgery},
year = {2024},
doi = {10.5761/atcs.oa.23-00076}
}
EUVIMED